AMRC
BEARISH
$32.51
Live
Ameresco, Inc. · NYSE
Target $43.5
(+33.8%)
$8.49
52W Range
$44.93
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$1.72B
P/E
27.55
ROE
6.6%
Profit margin
3.3%
Debt/Equity
2.25
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
68%
The company exhibits weak financial health with a Piotroski F-Score of just 2/9, indicating significant fundamental deterioration. Despite recent earnings surprises and positive short-term growth momentum, high leverage (Debt/Equity of 2.25), low profitability margins, and a lack of Altman Z-Score due to potential distress risk raise serious concerns. The stock trades well above its Graham Number of $23.05 and intrinsic value of $19.06, implying overvaluation relative to defensive and growth-based metrics. Bearish insider activity and inconsistent earnings performance further undermine confidence in a sustainable turnaround.
Key Strengths
Recent quarterly earnings have shown strong positive surprises, with an average surprise of 115.7% over the last four quarters
Year-over-year revenue and earnings growth are positive at 5.0% and 6.1%, respectively
Current ratio of 1.51 and quick ratio of 1.20 suggest adequate short-term liquidity
Analyst consensus recommendation is 'buy' with a target price of $43.50, implying 33.8% upside
Stock has rebounded strongly in the past six months (+79.4%), outperforming peers
Key Risks
Critically low Piotroski F-Score of 2/9 signals weak financial health and deteriorating fundamentals
Debt/Equity ratio of 2.25 is high, increasing financial risk, especially in a rising rate environment
Profitability metrics are weak: ROA of 1.50%, ROE of 6.62%, and net margin of 3.34% lag behind sector averages
Insiders have been aggressively selling, with $1.84M in net sales over the last six months, including multiple CFO transactions
Long-term price performance is poor: down 49.3% over 3 years despite recent rebound
AI Fair Value Estimate
Based on comprehensive analysis
$21.05
-35.3% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
29
Weak
28
54
42
22
0
AI Verdict
Financially weak with overvaluation and insider skepticism outweighing recent earnings momentum
Key drivers: Low Piotroski F-Score (2/9), High Debt/Equity (2.25), Stock trading above Graham Number ($23.05) and intrinsic value ($19.06), Bearish insider activity, Recent earnings volatility and declining long-term performance
Confidence
70%
Value
28/100
Ref P/E, PEG, Graham Number
Positives
- P/E of 27.55 is below sector average of 48.27
Watchpoints
- Price/Sales of 0.91 lacks margin of safety
- Current price ($32.51) significantly above Graham Number ($23.05)
- Intrinsic value estimate of $19.06 suggests deep overvaluation
Future
54/100
Ref Growth rates
Positives
- Positive YoY earnings growth of 6.1%
- Q/Q EPS growth of 5.3% and most recent Q/Q EPS growth of +29.6%
Watchpoints
- PEG Ratio is unavailable, suggesting unreliable growth expectations
- Forward P/E of 27.11 remains high relative to growth rate
Past
42/100
Ref Historical trends
Positives
- Recent quarters show strong earnings surprises (e.g., +274.6% in Q3 2025)
Watchpoints
- Erratic earnings performance with multiple large misses in prior quarters
- 3-year total return of -49.3% indicates prolonged underperformance
Health
22/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Current ratio of 1.51 and quick ratio of 1.20 indicate short-term solvency
Watchpoints
- Piotroski F-Score of 2/9 indicates severe financial weakness
- Altman Z-Score is unavailable, raising red flag for potential distress
- Debt/Equity of 2.25 is elevated for the sector
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- No dividend yield or payout history
- Dividend strength score of 0/100
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$32.51
Analyst Target
$43.5
Upside/Downside
+33.8%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for AMRC and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
AMRC
Ameresco, Inc.
Primary
|
-43.5% | -49.3% | +43.4% | +79.4% | +7.2% | -1.9% |
|
HLMN
Hillman Solutions Corp.
Peer
|
-20.8% | +8.9% | +15.0% | -9.6% | +4.6% | -0.7% |
|
CBZ
CBIZ, Inc.
Peer
|
-7.9% | -39.8% | -53.8% | -42.5% | +19.9% | +2.2% |
|
CMPR
Cimpress plc
Peer
|
-30.3% | +71.5% | +78.1% | +17.5% | +3.2% | +1.4% |
|
PSIX
Power Solutions International, Inc.
Peer
|
+1037.1% | +2562.2% | +224.8% | -8.6% | +48.0% | +2.5% |
AMR
Ameresco, Inc.
Primary
5Y
-43.5%
3Y
-49.3%
1Y
+43.4%
6M
+79.4%
1M
+7.2%
1W
-1.9%
HLM
Hillman Solutions Corp.
Peer
5Y
-20.8%
3Y
+8.9%
1Y
+15.0%
6M
-9.6%
1M
+4.6%
1W
-0.7%
CBZ
CBIZ, Inc.
Peer
5Y
-7.9%
3Y
-39.8%
1Y
-53.8%
6M
-42.5%
1M
+19.9%
1W
+2.2%
CMP
Cimpress plc
Peer
5Y
-30.3%
3Y
+71.5%
1Y
+78.1%
6M
+17.5%
1M
+3.2%
1W
+1.4%
PSI
Power Solutions International, Inc.
Peer
5Y
+1037.1%
3Y
+2562.2%
1Y
+224.8%
6M
-8.6%
1M
+48.0%
1W
+2.5%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
27.55
Forward P/E
27.11
PEG Ratio
N/A
P/B Ratio
1.62
P/S Ratio
0.91
EV/Revenue
2.19
EV/EBITDA
20.18
Market Cap
$1.72B
Profitability
Profit margins and return metrics
Profit Margin
3.34%
Operating Margin
7.79%
Gross Margin
14.67%
ROE
6.62%
ROA
1.5%
Growth
Revenue and earnings growth rates
Revenue Growth
+5.0%
Earnings Growth
+6.1%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
+5.3%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
2.25
High debt
Current Ratio
1.51
Good
Quick Ratio
1.2
Good
Cash/Share
$1.79
Quarterly Earnings History
EPS performance vs analyst estimates
2026-03-02
$N/A
2025-11-03
$0.35
+16.0% surprise
2025-08-04
$0.27
+274.6% surprise
2025-05-05
$-0.11
+56.5% surprise
Industrials Sector Comparison
Comparing AMRC against 469 companies in the Industrials sector
(39 bullish, 174 neutral, 256 bearish)
P/E Ratio
27.55
This Stock
vs
98.24
Sector Avg
-72.0%
(Discount)
Return on Equity (ROE)
6.62%
This Stock
vs
-19.38%
Sector Avg
-134.1%
(Below Avg)
Profit Margin
3.34%
This Stock
vs
6.65%
Sector Avg
-49.7%
(Weaker)
Debt to Equity
2.25
This Stock
vs
2.63
Sector Avg
-14.6%
(Lower)
Revenue Growth
5.0%
This Stock
vs
71.29%
Sector Avg
-93.0%
(Slower)
Current Ratio
1.51
This Stock
vs
3.09
Sector Avg
-51.1%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
AMRC
Ameresco, Inc.
|
BEARISH | $1.72B | 27.55 | 6.6% | 3.3% | $32.51 | |
|
HLMN
Hillman Solutions Corp.
|
NEUTRAL | $1.73B | 44.05 | 3.3% | 2.6% | $8.81 | Compare |
|
CBZ
CBIZ, Inc.
|
NEUTRAL | $1.68B | 16.76 | 6.5% | 4.2% | $30.67 | Compare |
|
CMPR
Cimpress plc
|
BEARISH | $1.83B | 75.54 | -% | 0.7% | $74.03 | Compare |
|
PSIX
Power Solutions International, Inc.
|
NEUTRAL | $1.83B | 16.11 | 93.5% | 15.8% | $79.6 | Compare |
AMRC
Ameresco, Inc.
BEARISH
Mkt Cap
$1.7B
P/E
27.6
ROE
6.6%
Price
$32.51
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-13 | CHIPLOCK MARK A | Chief Financial Officer | Sale | 23,899 | $1,001,181 |
| 2025-10-13 | CHIPLOCK MARK A | Chief Financial Officer | Option Exercise | 23,899 | $309,330 |
| 2025-10-08 | CHIPLOCK MARK A | Chief Financial Officer | Sale | 15,600 | $613,787 |
| 2025-10-08 | CHIPLOCK MARK A | Chief Financial Officer | Option Exercise | 15,600 | $208,572 |
| 2025-10-01 | CHIPLOCK MARK A | Chief Financial Officer | Sale | 5,602 | $212,596 |
| 2025-10-01 | CHIPLOCK MARK A | Chief Financial Officer | Option Exercise | 5,602 | $69,799 |
| 2025-09-15 | CHIPLOCK MARK A | Chief Financial Officer | Sale | 269 | $7,532 |
| 2025-09-15 | CORRSIN DAVID J | General Counsel | Sale | 19 | $532 |
| 2025-09-10 | CORRSIN DAVID J | General Counsel | Sale | 19 | $514 |
| 2025-09-10 | BAKAS MICHAEL T. | Officer | Stock Award | 875 | - |
| 2025-09-10 | BULGARINO NICOLE E | Officer | Stock Award | 875 | - |
| 2025-09-10 | MALTEZOS LOUIS P | Officer | Stock Award | 875 | - |
| 2025-09-10 | CORRSIN DAVID J | General Counsel | Stock Award | 50 | - |
| 2025-09-10 | CHIPLOCK MARK A | Chief Financial Officer | Stock Award | 750 | - |
| 2025-09-10 | CHRISTAKIS PETER | Officer | Stock Award | 750 | - |
CHIPLOCK MARK A
Chief Financial Officer
2025-10-13
23,899 shares
·
$1,001,181
CHIPLOCK MARK A
Chief Financial Officer
2025-10-13
23,899 shares
·
$309,330
CHIPLOCK MARK A
Chief Financial Officer
2025-10-08
15,600 shares
·
$613,787
CHIPLOCK MARK A
Chief Financial Officer
2025-10-08
15,600 shares
·
$208,572
CHIPLOCK MARK A
Chief Financial Officer
2025-10-01
5,602 shares
·
$212,596
CHIPLOCK MARK A
Chief Financial Officer
2025-10-01
5,602 shares
·
$69,799
CHIPLOCK MARK A
Chief Financial Officer
2025-09-15
269 shares
·
$7,532
CORRSIN DAVID J
General Counsel
2025-09-15
19 shares
·
$532
CORRSIN DAVID J
General Counsel
2025-09-10
19 shares
·
$514
BAKAS MICHAEL T.
Officer
2025-09-10
875 shares
BULGARINO NICOLE E
Officer
2025-09-10
875 shares
MALTEZOS LOUIS P
Officer
2025-09-10
875 shares
CORRSIN DAVID J
General Counsel
2025-09-10
50 shares
CHIPLOCK MARK A
Chief Financial Officer
2025-09-10
750 shares
CHRISTAKIS PETER
Officer
2025-09-10
750 shares
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
10 analysts
UBS
2025-12-03
Neutral
Neutral
Stifel
2025-11-14
Buy
Buy
Roth Capital
2025-11-03
Buy
Buy
B. Riley Securities
2025-10-31
Buy
Buy
Jefferies
2025-09-25
Hold
Buy
B. Riley Securities
2025-09-10
Buy
Buy
Baird
2025-09-02
Neutral
Outperform
UBS
2025-08-18
Sell
Neutral
Past News Coverage
Recent headlines mentioning AMRC from our newsroom.
Newest → oldest
No matching news yet.